| Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease (NCT06833541) | The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine | 2022-04-18 |
| A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects (NCT05294458) | AstraZeneca | 2022-03-28 |
| The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency (NCT06883656) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2022-03-15 |
| Adiponectin in Patients With Metabolic Disorders (NCT07539584) | Moscow Regional Research and Clinical Institute (MONIKI) | 2022-03-01 |
| Dapagliflozin Effect on Erythropoiesis and Physical Fitness (NCT03423355) | University Hospital Tuebingen | 2021-09-01 |
| Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF (NCT06660134) | Shanghai Chest Hospital | 2021-08-01 |
| Combination of Bitter Melon Extract and Snakehead Fish Powder to Reduce Glycaemia in Type 2 Diabetes Mellitus (NCT07303127) | Universitas Muhammadiyah Surakarta | 2021-06-01 |
| NAFF Arabic Validation Study (NCT07271550) | Faculty of Medicine, Sousse | 2021-06-01 |
| A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes (NCT04809220) | Eli Lilly and Company | 2021-04-13 |
| Technology-Based Education and Follow-Up in Type 2 Diabetes Management (NCT07513961) | Alanya Alaaddin Keykubat University | 2021-03-15 |
| Quinoa Improves Glycolipid Metabolism and Glucose Fluctuation Based on β-Cell Function in Early-stage Type 2 Diabetes (NCT07329231) | Qilu Hospital of Shandong University | 2021-01-10 |
| Low-Dose Pioglitazone in Patients With NASH (AIM 2) (NCT04501406) | University of Florida | 2020-12-15 |
| Individualized Medical Nutrition Therapy in Adults With Type 2 Diabetes Mellitus (NCT07037212) | Serap Balaban Barta | 2020-12-15 |
| Comparison of Thrice-Daily Premixed Human Insulin With Basal-Bolus Therapy Among Patients With Poorly Controlled Type 2 Diabetes Mellitus (NCT06855615) | Hospital Sultanah Aminah Johor Bahru | 2020-10-01 |
| Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy (NCT04504396) | PegBio Co., Ltd. | 2020-06-23 |
| Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects (NCT04504370) | PegBio Co., Ltd. | 2020-04-27 |
| Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus (NCT03774394) | University of Florida | 2019-08-22 |
| Comparative Outcomes of One-Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass As Revisional Procedures Following Failed Restrictive Bariatric Surgery (NCT06794892) | Azienda Sanitaria Locale Napoli 2 Nord | 2019-01-01 |
| A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) (NCT03656744) | HighTide Biopharma Pty Ltd | 2018-11-26 |
| Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes (NCT03604419) | PegBio Co., Ltd. | 2018-06-13 |
| A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM) (NCT02759107) | Eli Lilly and Company | 2016-05-11 |
| Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings (NCT02643797) | Scripps Whittier Diabetes Institute | 2016-03-07 |
| A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation (NCT02672839) | Ligand Pharmaceuticals | 2016-02-01 |
| Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months. (NCT02670928) | Novartis Pharmaceuticals | 2015-07-20 |
| SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study (NCT07198191) | Yonsei University | 2014-09-01 |
| Multiple Electrode Aggregometry & Clopidogrel Resistance (NCT01991093) | Elpen Pharmaceutical Co. Inc. | 2014-06-01 |
| Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients (NCT02002221) | Novartis Pharmaceuticals | 2013-12-01 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease (NCT02218099) | Astellas Pharma Europe B.V. | 2013-09-16 |
| Multiple Dose Study Of PF-05231023 In Obese Adult Subjects (NCT01923389) | Pfizer | 2013-09-01 |
| Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin (NCT01871558) | Novartis Pharmaceuticals | 2013-06-01 |
| A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration (NCT01755494) | AstraZeneca | 2013-02-01 |
| Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM) (NCT01407003) | Novartis Pharmaceuticals | 2011-06-01 |
| Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263) (NCT01131182) | Merck Sharp & Dohme LLC | 2010-06-13 |
| A Radiolabeled Mass Balance Study of [14C]-Ertugliflozin (PF04971729, MK-8835) In Healthy Male Participants (MK-8835-038) (NCT01127308) | Merck Sharp & Dohme LLC | 2010-06-01 |
| Diabetes & Vardenafil (NCT02219646) | Azienda USL Modena | 2010-03-01 |
| Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes (NCT06913881) | Karolinska Institutet | 2010-01-01 |
| Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State (NCT01002807) | AstraZeneca | 2009-11-01 |
| Acarbose Cardiovascular Evaluation Trial (NCT00829660) | University of Oxford | 2009-02-17 |
| Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061) (NCT00511108) | Merck Sharp & Dohme LLC | 2007-07-11 |
| Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059) (NCT00704132) | Merck Sharp & Dohme LLC | 2007-02-14 |
| Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (NCT00337610) | Merck Sharp & Dohme LLC | 2006-06-01 |